ArticleActa neuropathologica communications2019

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.

Yu Kanemaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.